Citadel Advisors
AMED

Citadel Advisors’s Amedisys AMED Stock Holding History

Citadel Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-95,000
Closed -$9.35M – 12678
2025
Q2 		$9.35M Buy
95,000
+6,200
+7% +$587K ﹤0.01% 3119
2025
Q1 		$8.23M Buy
88,800
+10,400
+13% +$959K ﹤0.01% 3122
2024
Q4 		$7.12M Buy
78,400
+74,800
+2,078% +$6.87M ﹤0.01% 3423
2024
Q3 		$347K Sell
3,600
-18,600
-84% -$1.81M ﹤0.01% 9022
2024
Q2 		$2.04M Buy
22,200
+19,800
+825% +$1.84M ﹤0.01% 5265
2024
Q1 		$221K Buy
2,400
+1,300
+118% +$122K ﹤0.01% 10115
2023
Q4 		$105K Buy
1,100
+600
+120% +$56K ﹤0.01% 10879
2023
Q3 		$46.7K Sell
500
-800
-62% -$73.9K ﹤0.01% 11834
2023
Q2 		$119K Sell
1,300
-14,600
-92% -$1.2M ﹤0.01% 10672
2023
Q1 		$1.17M Sell
15,900
-20,200
-56% -$1.75M ﹤0.01% 6439
2022
Q4 		$3.02M Buy
36,100
+18,400
+104% +$1.66M ﹤0.01% 4740
2022
Q3 		$1.71M Sell
17,700
-49,800
-74% -$5.94M ﹤0.01% 5880
2022
Q2 		$7.1M Buy
67,500
+22,100
+49% +$2.82M ﹤0.01% 3181
2022
Q1 		$7.82M Sell
45,400
-4,100
-8% -$613K ﹤0.01% 3362
2021
Q4 		$8.01M Sell
49,500
-5,600
-10% -$900K ﹤0.01% 3447
2021
Q3 		$8.21M Buy
55,100
+30,400
+123% +$6.32M ﹤0.01% 3415
2021
Q2 		$6.05M Buy
24,700
+12,900
+109% +$3.38M ﹤0.01% 4048
2021
Q1 		$3.13M Buy
11,800
+3,800
+48% +$1.07M ﹤0.01% 5348
2020
Q4 		$2.35M Sell
8,000
-2,500
-24% -$641K ﹤0.01% 5028
2020
Q3 		$2.48M Sell
10,500
-11,100
-51% -$2.52M ﹤0.01% 4316
2020
Q2 		$4.29M Sell
21,600
-1,800
-8% -$336K ﹤0.01% 3303
2020
Q1 		$4.29M Sell
23,400
-9,000
-28% -$1.6M ﹤0.01% 2930
2019
Q4 		$5.41M Buy
32,400
+23,800
+277% +$3.54M ﹤0.01% 2980
2019
Q3 		$1.13M Sell
8,600
-2,800
-25% -$365K ﹤0.01% 5390
2019
Q2 		$1.38M Sell
11,400
-31,600
-73% -$3.75M ﹤0.01% 5150
2019
Q1 		$5.3M Buy
43,000
+8,800
+26% +$1.1M ﹤0.01% 2922
2018
Q4 		$4M Buy
34,200
+16,800
+97% +$1.98M ﹤0.01% 3101
2018
Q3 		$2.17M Buy
17,400
+12,500
+255% +$1.38M ﹤0.01% 4266
2018
Q2 		$419K Sell
4,900
-4,800
-49% -$352K ﹤0.01% 6663
2018
Q1 		$585K Sell
9,700
-7,300
-43% -$416K ﹤0.01% 5628
2017
Q4 		$896K Buy
+17,000
New +$896K ﹤0.01% 4811
2017
Q3 		– Sell
-5,600
Closed -$352K – 7483
2017
Q2 		$352K Buy
5,600
+1,000
+22% +$58.2K ﹤0.01% 5639
2017
Q1 		$235K Sell
4,600
-2,100
-31% -$100K ﹤0.01% 6262
2016
Q4 		$286K Buy
+6,700
New +$285K ﹤0.01% 5745
2016
Q3 		– Sell
-5,700
Closed -$288K – 7193
2016
Q2 		$288K Sell
5,700
-14,400
-72% -$727K ﹤0.01% 5271
2016
Q1 		$972K Buy
20,100
+8,400
+72% +$324K ﹤0.01% 3527
2015
Q4 		$460K Sell
11,700
-1,000
-8% -$40K ﹤0.01% 4572
2015
Q3 		$482K Sell
12,700
-29,800
-70% -$1.26M ﹤0.01% 4857
2015
Q2 		$1.69M Buy
42,500
+36,800
+646% +$1.15M ﹤0.01% 3259
2015
Q1 		$153K Sell
5,700
-5,400
-49% -$152K ﹤0.01% 6459
2014
Q4 		$326K Buy
11,100
+5,700
+106% +$141K ﹤0.01% 5313
2014
Q3 		$109K Sell
5,400
-7,900
-59% -$152K ﹤0.01% 6321
2014
Q2 		$223K Sell
13,300
-5,900
-31% -$83.6K ﹤0.01% 5450
2014
Q1 		$286K Buy
19,200
+9,400
+96% +$145K ﹤0.01% 5077
2013
Q4 		$143K Sell
9,800
-14,500
-60% -$233K ﹤0.01% 5323
2013
Q3 		$418K Buy
24,300
+3,900
+19% +$57.9K ﹤0.01% 3995
2013
Q2 		$237K Buy
+20,400
New +$234K ﹤0.01% 4515

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's AMED Position: Q3 2025 in Review

Citadel Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 128,947 shares — an estimated $12.7M sold.

Citadel Advisors first reported a position in AMED in Q4 2013 and held it in 42 quarters. The position peaked at $79.3M in Q4 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Citadel Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 128,947 Amedisys shares in Q3 2025, an estimated $12.7M.
  • Citadel Advisors first reported a position in Amedisys in Q4 2013 and held it in 42 quarters.
  • Citadel Advisors's Amedisys position peaked at $79.3M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.